These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 861135)

  • 21. Comparative study of the absorption, plasma levels, and urinary excretion of the "new" and the "old" Lanoxin.
    Falch D; Teien A; Bjerkelund CJ
    Br Med J; 1973 Mar; 1(5855):695-7. PubMed ID: 4694690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Greater bioavailability of digoxin solution in capsules. Studies in the postprandial state.
    Lindenbaum J
    Clin Pharmacol Ther; 1977 Mar; 21(3):278-82. PubMed ID: 576419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The assessment of the intrasubject variability in digoxin absorption in man from two oral dosage forms.
    Yacobi A; Stoll RG; Chao GC; Schwartz RA; Weidler DJ; Ayers JW; Sakmar E; Hallmark M; Wagner JG
    J Clin Pharmacol; 1981 Jul; 21(7):301-10. PubMed ID: 7263929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of dietary fiber on the bioavailability of digoxin in capsules.
    Johnson BF; Rodin SM; Hoch K; Shekar V
    J Clin Pharmacol; 1987 Jul; 27(7):487-90. PubMed ID: 2821081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Digoxin solution in capsules (Lanoxicaps).
    Med Lett Drugs Ther; 1983 Dec; 25(650):111-2. PubMed ID: 6656690
    [No Abstract]   [Full Text] [Related]  

  • 26. Bioavailability of digoxin in a new soluble pharmaceutical formulation in capsules.
    Ghirardi P; Catenazzo G; Mantero O; Merotti GC; Marzo A
    J Pharm Sci; 1977 Feb; 66(2):267-9. PubMed ID: 839426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased digoxin cardioinactive-reduced metabolites after administration as an encapsulated liquid concentrate.
    Rund DG; Lindenbaum J; Dobkin JF; Butler VP; Saha JR
    Clin Pharmacol Ther; 1983 Dec; 34(6):738-43. PubMed ID: 6641088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of soft gelatin on digoxin absorption.
    O'Grady J; Johnson BF; Bye C; Sabey GA
    Br J Clin Pharmacol; 1978 May; 5(5):461-3. PubMed ID: 656286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of metoclopramide on digoxin absorption from tablets and capsules.
    Johnson BF; Bustrack JA; Urbach DR; Hull JH; Marwaha R
    Clin Pharmacol Ther; 1984 Dec; 36(6):724-30. PubMed ID: 6499354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and bioavailability of digoxin capsules, solution and tablets after single and multiple doses.
    Lloyd BL; Greenblatt DJ; Allen MD; Harmatz JS; Smith TW
    Am J Cardiol; 1978 Jul; 42(1):129-36. PubMed ID: 677028
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model.
    Bansinath M; Ghosh SS; Shukla VK; Chopra KS; Mathur VS
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):303-7. PubMed ID: 3724304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Superior bioavailability of digoxin solution in capsules.
    Mallis GI; Schmidt DH; Lindenbaum J
    Clin Pharmacol Ther; 1975 Dec; 18(6):761-8. PubMed ID: 1106935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Biologic availability of digoxin in soft gelatin capsules and in tablets].
    Merotti GC; Ghirardi P; Marzo A; Parenti MA
    Boll Soc Ital Biol Sper; 1974 Oct; 50(19):1612-4. PubMed ID: 4458749
    [No Abstract]   [Full Text] [Related]  

  • 34. The bioavailability of digoxin from three oral formulations measured by a specific h.p.l.c. assay.
    Cohen AF; Kroon R; Schoemaker HC; Breimer DD; Van Vliet-Verbeek A; Brandenburg HC
    Br J Clin Pharmacol; 1993 Feb; 35(2):136-42. PubMed ID: 8443031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bioavailability of digoxin tablets in cardiac insufficiency patients].
    Kholodov LE; Grigor'eva EA; Glezer MG; Sabel'nikova EA
    Kardiologiia; 1980 Oct; 20(10):68-73. PubMed ID: 7441963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Equivalent bioavailability from digoxin elixir and rapid-dissolution tablets.
    Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
    JAMA; 1974 Sep; 229(13):1774-6. PubMed ID: 4479121
    [No Abstract]   [Full Text] [Related]  

  • 37. Single dose bioavailability of two different digoxin tablets.
    Jonkman JH; Gusdorf CF; van der Boon WJ; Grasmeijer G; Jedema JN
    Arzneimittelforschung; 1987 Jan; 37(1):62-5. PubMed ID: 3566859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absorption of beta-methyl-digoxin determined after a single dose and under steady state conditions.
    Boerner D; Olcay A; Schaumann W; Weiss W
    Eur J Clin Pharmacol; 1976 Feb; 9(4):307-14. PubMed ID: 971714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioavailability of digoxin in capsules.
    Padeletti L; Brat A
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):320-2. PubMed ID: 669878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biological availability of digoxin and beta-acetyldigoxin after single-dose administration (author's transl)].
    Clasen R; Kemmeter H; Gilfrich HJ
    Dtsch Med Wochenschr; 1979 Apr; 104(15):543-6. PubMed ID: 436626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.